FDA Approved: CYSTAGON — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for CYSTAGON (cysteamine bitartrate) submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathic Cystinosis

Drugs mentioned

• Cystagon (cysteamine bitartrate)

Snippet

SUPPL AP for CYSTAGON (CYSTEAMINE BITARTRATE)